News Release
For Immediate Release
December 13, 2018
Sawai Pharmaceutical Co., Ltd.

Sawai Launches Six Generic Drugs with 14 Strengths
Osaka, Japan – December 13, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka,Japan, President: Mitsuo Sawai) today announced the launch of six compounds with 14 strengths ofgeneric drugs. They will be launched sequentially beginning tomorrow. Sawai’s product line now
includes 310* compounds with 756 strengths. Among the six compounds, four compounds, “Mirtazapine”,“Atomoxetine Hydrochloride”, “Tramadol Hydrochloride and Acetaminophen” and “Capecitabine", will belaunched for the first time as generics.
®

* TOARASET Combination Tablets are Tramadol Hydrochloride and Acetaminophen, and are counted as onecompound.
®
* FREWELL Combination Tablets are Norethisterone and Ethinylestradiol, and are counted as one compound.

The list of new products:
1. MIRTAZAPINE OD Tablets 15 mg [SAWAI] and 30 mg [SAWAI],MIRTAZAPINE Tablets 15 mg [SAWAI] and 30 mg [SAWAI]
・Generic name:・Indications:・Brand products:

Mirtazapine
Depression and depressive state
REFLEX® TABLETS 15 mg and 30 mg,REMERON® Tablets 15 mg and 30 mg

・Striking features: Orally disintegrating (OD) tablets are the first dosage form for

Mirtazapine. Sawai aimed to improve patient convenience bydeveloping OD tablets which are taken at bedtime without water.
In addition, “Product name” and “Strength” are printed on thetablets, allowing the product to be identified even after removingfrom blister packs.
2. ATOMOXETINE Capsules 5 mg [SAWAI], 10 mg [SAWAI], 25 mg [SAWAI] and 40 mg [SAWAI]
・Generic name:
Atomoxetine Hydrochloride
・Indications:
Attention-deficit and hyperactivity disorder (ADHD)・Brand products:
Strattera® Capsules 5mg, 10 mg, 25 mg and 40 mg
・Striking features: The capsules are miniaturized and are printed with the “Genericname” and “Strength”.
3. TOARASET® Combination Tablets [SAWAI]
・Generic name:・Indications:

Tramadol Hydrochloride and Acetaminophen
Non-cancerous chronic pain and pain after tooth extraction that cannot be
managed by treatments with non-opioid analgesics
TRAMCET® Combination Tablets

・Brand products:
・Striking features: The “Product name” is printed on

both sides of tablet.
“Therapeutic category”, “Productname” and “Generic name andStrength” are indicated on theblister pack.

News Release
4. ROPINIROLE Extended-release Tablets 2 mg [SAWAI] and 8 mg [SAWAI]
・Generic name:・Indications:・Brand products:

Ropinirole Hydrochloride
Parkinson’s disease
ReQuip® CR Tablets 2 mg and 8 mg

5. FREWELL® Combination Tablets LD [SAWAI] and ULD [SAWAI]
・Generic name:
Norethisterone and Ethinylestradiol
・Indications:Dysmenorrhea
・Brand products:
LUNABELL® Tablets LD and ULD・Striking features: The blister pack can be set to theinstruction card. And easy for disposal.

Instruction card

6. CAPECITABINE Tablets 300 mg [SAWAI]
・Generic name:
Capecitabine
・Indications:
Inoperable or recurrent breast cancer, colorectal cancer, gastric cancer
・Brand products:
XELODA® Tablets 300
・Striking features: Sawai is launching the first generic of this product. Sinceanti-cancer treatment can be lengthy, generic drugs play animportant role to help patients financially.
A special feature of packages:
Crushable packaging box
This box can be easily crushed
upon disposal.
Thisfeatureapplies
toMIRTAZAPINE OD Tablets,
MIRTAZAPINE Tablets, andCombination
TOARASET®
Tablets.
Push from above with both hands◆ Contact Information ◆PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd.
E-mail：koho@sawai.co.jp